EMJ Podcast: Insights For Healthcare Professionals

In this episode, Viktor Grünwald shares his journey through a remarkable career in oncology, his focus on urogenital cancers, and his hopes for the future of cancer treatment. From reflections on research to European Society for Medical Oncology (ESMO) 2025 predictions and the promise of precision medicine, Grünwald offers an insightful look at evolving therapies and the pursuit of higher cure rates.

Timestamps:

00:00 – Introduction

01:03 – Reflections on his career

02:06 – Balancing research, clinical duties, and teaching

03:10 – Specialising in urogenital cancers

04:50 – Viktor's hobbies and interests

05:47 – Current landscape of genitourinary cancers

09:09 – Treatment modalities

11:09 – The CLEAR study

12:54 – European Society for Medical Oncology (ESMO) 2025 predictions

15:57 – The potential of precision medicine

19:09 – Viktor's three wishes for healthcare

Disclosure: Grünwald has received honoraria from Bristol Myers Squibb, Ipsen, Eisai, MSD Oncology, Merck Serono, AstraZeneca, Advanced Accelerator Applications (acquired by Novartis), Astellas Pharma, Amgen, Johnson & Johnson/Janssen, Telix Pharmaceuticals, Gilead Sciences, and Roche; research funding from Amgen, MSD Oncology, Bristol Myers Squibb, Seattle Genetics (now Seagen; acquired by Pfizer), Ipsen, Gilead Sciences, Bicycle Therapeutics, Exelixis, Novartis, Roche, and Johnson & Johnson/Janssen, with payment to the institution; travel/accommodation/expenses from Pfizer, Janssen, Merck Serono, Ipsen, and Amgen; and held consulting or advisory roles for Bristol Myers Squibb, Pfizer, Novartis, MSD Oncology, Ipsen, Janssen-Cilag, Eisai, Debiopharm, Gilead Sciences, Oncorena, Synthekine, and Recordati.

The CLEAR study was sponsored Eisai and Merck Sharp & Dohmre.

Susanna Esposito joins Saranya Ravindran to explore how clinicians can distinguish viral from bacterial respiratory infections in children. From bronchiolitis management to targeted testing, stewardship strategies, and the role of vitamin D and point-of-care diagnostics, this episode unpacks evidence-based approaches to reduce unnecessary antibiotic use.

Timestamps:

00:00 – Introduction

02:00 – Respiratory infections

03:30 – Targeted testing

04:12 – Antibiotics in bronchiolitis

05:52 – Stewardship initiatives

07:12 – Vitamin D in prevention

08:21 – Viral point-of-care diagnostics

In this rapid-fire episode, Susanna Esposito answers key questions about antimicrobial stewardship in children, from identifying viral versus bacterial infections, to emerging diagnostics and best practices for rational antibiotic use. Perfect for listeners short on time.

In this special World Mental Health Day episode, Jonathan Sackier speaks with Debi Roberts about breaking down barriers to mental health conversations and creating practical pathways for suicide prevention. From developing the Safe Plan and Prescription Safe Plan, to applying the Theory of Constraints in mental health systems, Debi brings clarity and compassion to one of society's most complex challenges. Together, they explore how education, storytelling, and community collaboration can empower individuals to act, connect, and care.

Timestamps

00:00 – Introduction

03:30 – Debi's career path

05:52 – Emotional literacy

08:15 – OLLIE Foundation

11:00 – Debi's current work

13:53 – Unpacking 'safe plans'

16:55 – The Prescription Safe Plan

21:23 – Theory of Constraints in suicide prevention

26:57 – Theory of Constraints in healthcare

33:00 – Societal views on suicide

39:49 – Reaching younger audiences

42:13 – It takes a village

46:05 – A message on World Mental Health Day

Description: In the final episode, Sandy Phanor delves into how her background in law helps her to maintain her confidentiality and professionalism in the clinic. She also looks towards the future, discussing technological advancements and the future of holistic care.

Timestamps:

01:14 – Law influence

02:15 – Osteopathy evolution

03:26 – Personalised plans

05:19 – Future technologies

7:00 – Holistic future

Description: What role does osteopathy play in sports injury rehab? And how does it differ between an office worker and an athlete? Sandy Phanor answers these questions, as well as explaining the benefits of good patient education in preventing repeat injuries.

Timestamps:

01:19 – Sports people

03:18 – Balancing recovery

04:30 – Office versus athletics

05:29 – Interesting case

06:51 – Patient education

In this episode of Hema Now, the authors sit down with Sunil Gupta to explore how advances in haematology are transforming both research and patient care. From breaking down misconceptions about stem cell donation to discussing emerging technologies, such as machine learning, Gupta shares insights into the breakthroughs, challenges, and future directions in the field. The episode also highlights his latest research and key takeaways from EHA2025, offering listeners a unique perspective on where haematology is heading next.

Timestamps:

00:00 – Introduction

01:54 – Biggest breakthrough in haematology

02:59 – Biggest challenge persisting

03:50 – Misconceptions about stem cell donation

05:27 – Emerging technologies

05:55 – Overview of Sunil's research

09:30 – AI in haematology

13:01 – Key takeaways from EHA2025

17:56 – Translating research into patient care

Sandy Phanor reflects on her experiences in the clinic and explains how she harnesses the power of emotional connection with her patients, who now actively seek osteopathic appointments. Additionally, she explains her internal flow chart to assess patients. and how she ensures she uses the right technique in each situation.

Timestamps:

01:16 – Emotional connection

03:18 – Emotional manifestations

05:59 – Which technique?

08:28 – Lifestyle effects

11:00 – Patient relationships

In this rapid-fire episode, Sandy Phanor answers quick questions about her craft, discussing misconceptions about osteopathy, common conditions such as back pain, common causes of conditions, such as slouching, and how she enjoys treating spinal issues the most.

This episode provides timely coverage of the 2025 Meeting of the International Myeloma Society (IMS). Claudio Cerchione highlights the most important developments from the Annual Meeting, offers his reflections on the evolving treatment landscape, and discusses the role of research and collaboration in moving closer to a cure for myeloma.

Timestamps

00:00 – Introduction

02:08 – Reflections on his own career

04:20 – Claudio's initial interest in the field

06:46 – Key takeaways from IMS 2025 Meeting

10:09 – Any potential gaps in coverage?

11:50 – How different patient groups are identified

13:30 – Minimal residual disease

16:15 – Impact of medical societies

20:24 – Translating new findings into clinical practice

23:44 – Improving the accessibility of treatments

26:45 – Claudio's key takeaways from IMS 2025 Meeting

Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.